Nanodelivery systems have shown considerable promise in increasing the solubility and delivery efficiency of hydrophobic photosensitizers for photodynamic therapy (PDT) applications. In this study, we report the preparation and characterization of polymeric micelles that incorporate protoporphyrin IX (PpIX), a potent photosensitizer, using non-covalent encapsulation and covalent conjugation methods. Depending on the incorporation method and PpIX loading percentage, PpIX existed as a monomer, dimer or aggregate in the micelle core. The PpIX state directly affected the fluorescence intensity and 1 O 2 generation efficiency of the resulting micelles in aqueous solution. Micelles with lower PpIX loading density (e.g. 0.2%) showed brighter fluorescence and higher 1 O 2 yield than those with higher PpIX loading density (e.g. 4%) in solution. However, PDT efficacy in H2009 lung cancer cells showed an opposite trend. In particular, 4% PpIX-conjugated micelles demonstrated the largest PDT therapeutic window, as indicated by the highest phototoxicity and relatively low dark toxicity. Results from this study contribute to the fundamental understanding of nanoscopic structure-property relationships of micelle-delivered PpIX and establish a viable micelle formulation (i.e. 4% PpIX-conjugated micelles) for in vivo evaluation of antitumor efficacy.
Introduction
Recently, photodynamic therapy (PDT) has received considerable attention as a safe, minimally invasive and tissue selective treatment of cancer and other diseases [1] [2] [3] . During PDT, a photosensitizer (PS) drug is first intravenously administered into the patient. Upon light activation at the targeted tissues, singlet oxygen ( 1 O 2 ) and other reactive oxygen species (ROS) are generated to destroy malignant cells [4, 5] . Compared to other therapeutic modalities, PDT is much less invasive than surgery, and is more tumor-selective than chemotherapy and radiotherapy with minimal toxicity to normal tissues. Currently, Photofrin ® (porfimer sodium), Visudyne ® (verteporfin), Levulan ® (5-aminolevulinic acid, 5-ALA) and Metvixia ® (methyl aminolevulinic acid) have been approved as PDT drugs by the Food and Drug Administration in the US, and Foscan ® (temoporfin) has been approved to treat head and neck cancers in the European Union [3] . Except for 5-ALA, all the other clinically approved PDT drugs are porphyrin-based molecules, which are hydrophobic and have intrinsically low water solubilities. Excipient molecules such as lipid mixtures (e.g. in Visudyne ® ) and ethanol/poly(propylene glycol) (e.g. in Foscan ® ) are used to solubilize these agents for intravenous injections. 5-ALA is a pro-drug that can be converted into protoporphyrin IX (PpIX) in rapidly proliferating tumor cells compared to normal tissues leading to selective accumulation of PpIX in tumors [6, 7] . The endogenously produced PpIX in turn acts as a potent PS allowing selective destruction of cancer cells. A major disadvantage of this approach is the limited diffusion of 5-ALA through cell membranes because of its polarity. Moreover, it is unstable in aqueous solution from the neutral to basic pH range. In the clinical setting, high doses of 5-ALA must be administered to reach clinically efficacious levels of PpIX. So far, free PpIX cannot be directly injected intravenously due to its low water solubility (~1 μg/mL). Moreover, dark toxicity as well as easy aggregation of PpIX leading to a rapid loss of its ability to generate singlet oxygen further limits the direct clinical use of PpIX [8, 9] .
Nanoparticles have been developed as an effective PDT drug delivery platform in recent years [10] , and extensive research efforts have been devoted to the development of effective nanocarriers for PDT agents including liposomes [11, 12] , dendrimers [13, 14] , polymer nanoparticles [15, 16] and polymeric micelles [17, 18] . Among these, polymeric micelles provide an intriguing option due to their unique core-shell structures in aqueous environment. The hydrophobic core of the micelles provides a naturally compatible environment for loading hydrophobic PS molecules, while the hydrophilic shells stabilize the nanoparticles for increased water solubility and prolong blood circulation. In addition to the solubility enhancement of hydrophobic agents into aqueous solution, micelle encapsulation can also greatly improve the photophysical and photochemical properties of PS in aqueous solution. Singlet oxygen is believed to be the main cytotoxic agent with PDT, and the properties of singlet oxygen are sensitive to the microenvironment surrounding the PS. The quantum yield, lifetime and diffusion distance of singlet oxygen will vary depending on whether it is generated by free PS in aqueous solution or PS encapsulated in micelles. Studies have shown longer 1 O 2 lifetimes and improved 1 O 2 generation when porphyrin-based PS is incorporated into micelle carriers [19] , and that the produced 1 O 2 in the micelle core can escape out of the core efficiently [20] . Moreover, the micelle formulation may protect PpIX from photobleaching by ROS and reacting with biomolecules directly. Another advantage of incorporating porphyrin-based PS agents into micelles includes the ability to prevent aggregation, which can interfere with PS efficacy and decrease the fluorescence of the PS dye. Previously, our lab reported the use of polymeric micelles for the delivery of imaging agents [21, 22] , and/or hydrophobic drugs [23, 24] for cancer diagnostic or therapeutic applications. In this study, we describe the use of micelle carriers for the delivery of PpIX using a biocompatible and biodegradable block copolymer, poly(ethylene glycol)-b-poly(D,Llactide) (PEG-PLA). A unique correlation of structure and photophysical properties of PpIX/PEG-PLA micelles was discovered. The fluorescence efficiency, 1 O 2 quantum yield and PDT efficacy in cancer cells were found to be highly dependent on the mode (i.e. physical encapsulation vs. covalent conjugation) and PpIX loading density. These results contribute to the fundamental understanding of the nanocarrier effect on the photophysical properties of PpIX-containing micelles, which will facilitate the implementation of these photosensitive nanoparticles for PDT treatment of cancer and other diseases. The PEG-PLA (molecular weights of PEG and PLA blocks are 5 kDa) copolymer was synthesized by ring-opening polymerization of D,L-lactide (Alfa Aesar, Ward Hill, MA) in dry toluene at 115°C for 24 h using MeO-PEG-OH as a macroinitiator and Sn(Oct) 2 as a catalyst following a published procedure [25] . For PEG-PLA-PpIX synthesis, PpIX (0.1 mmol, Sigma-Aldrich) was first dissolved in 20 mL dry THF. Then PEG-PLA (1.2 g), dicyclohexylcarbodiimide (0.1 mmol) and N, N-dimethylaminopyridine were added under dry nitrogen and stirred at room temperature for 48 h. After reaction, white precipitate of dicyclohexylurea was filtered and the filtrate was concentrated by rotavap. The residual mixture was dialyzed in distilled water and lyophilized. UV-vis analysis showed that 75% of PEG-PLA-OH end groups were conjugated with PpIX.
Micelle production and characterization
PpIX/PEG-PLA micelles were produced by a solvent evaporation method as previously reported [25] . Briefly, a proper amount of PEG-PLA and free PpIX or PEG-PLA-PpIX were first dissolved in THF with PpIX weight ratio varying from 0.04% to 4%. The mixture was added dropwise to distilled water under sonication and then allowed to evaporate overnight to remove THF. The resulting PpIX-micelles were purified by centrifugation dialysis (MW cutoff 100 kDa) to remove free PpIX.
The PpIX-micelles were characterized by TEM for particle morphology and zeta sizer (Malvern NanoZS) for zeta potential and hydrodynamic diameters. The PpIX loading density was measured by dissolving a solid micelle sample in THF and quantified by UV-vis analysis using a previously established calibration curve. The UV-vis absorption spectra of PpIX-micelles were recorded at room temperature using a Shimadzu UV spectrophotometer (UV-1800), and the emission spectra were obtained using a Hitachi fluorescence spectrophotometer (F-7000).
Singlet oxygen detection
The amount of 1 O 2 was measured by following the loss of UV absorbance or emission [26] of ADPA in the aqueous PpIX-micelle solutions. Briefly, a series of air-saturated PpIX-micelle solutions (1 mL) were prepared with anthracene-9,10-dipropionic acid (ADPA, 10 μM) and fresh PpIX micelles. The solution was illuminated under a laser light (λ = 532 nm, power density = 10 mW/cm 2 ). The consumptions of ADPA (A 0 -A t , A 0 and A t are the absorption of ADPA at 378 nm before and after irradiation, respectively) were followed by monitoring its absorption decrease at 378 nm over time. Relative 1 O 2 yields (Φ Δ ) were calculated by the slopes of the ADPA conversion and normalized to 0.2% PpIX-conjugated micelles.
PDT efficacy of PpIX-micelles in H2009 cells
H2009 human lung cancer cells were cultured in RPMI 1640 medium supplemented with 5% fetal bovine serum and antibiotics (Penicillin-Streptomycin) at 37°C in a 10% CO 2 humidified incubator. One day before the PDT treatments, H2009 cells were trypsinized using 0.05% trypsin-EDTA and seeded (10,000 cells/well) into 48-well plates. Cell culture media were then replaced by media containing predetermined doses of PpIX micelles and incubated for 24 h. For the PDT study, cells were illuminated with laser (λ = 532 nm, power density = 20 mW/cm 2 ) for 10 min. After irradiation, H2009 cells were allowed to grow for an additional 5 days in fresh media. Relative cell survival was measured by a DNA assay using Hoechst dye 33258 [27] and data were graphed as means of treated/control (T/C) ± SE × 100% from three independent experiments performed in sextuplicate. Dark toxicity was assessed from H2009 cells with PpIX-micelle incubation but without laser light exposure. Student's t-test was performed for statistical analysis (p value less than 0.05 was considered significant).
Confocal laser scanning microscopy of micelle uptake in H2009 cells
Confocal imaging studies were performed on a Nikon TE2000E confocal laser scanning microscope. H2009 cells were seeded in a glass-bottomed culture dish and allowed to attach overnight. The media were replaced with fresh media containing different PpIXmicelle samples at 100 μg/mL. H2009 cells were examined at different time points with a 600× total magnification (λ ex = 405 nm, λ em = 605 ± 35 nm). ImageJ software (National Institutes of Health) was utilized to quantify the mean fluorescence intensity (MFI) of the PpIX-micelles in vitro.
Results

Production and physical characterization of PpIX-micelles
Two series of PpIX/PEG-PLA micelles were generated: one through a non-covalent hydrophobic encapsulation strategy and another via covalent conjugation of PpIX to the hydroxyl group of PEG-PLA through ester linkage (Fig. 1A) . In both series, PpIX loading density (weight percentage of PpIX over micelles) was varied from 0.04% to 4%. Transmission electron microcopy (TEM) illustrated that PpIXcontaining micelles had a spherical morphology (Fig. 1B) . Dynamic light scattering (DLS) analysis showed that the micelle diameters were approximately 30 nm (Fig. 1C) , with slight although statistically insignificant increase of micelle size with an increase in PpIX loading density (Table 1) . Zeta potential (ξ) measurements showed that the micelle surface became more negatively charged with increased loading of PpIX in both series. For example, the ξ values decreased from − 6.9 ± 1.5 to − 13.3 ± 1.7 and −19.6 ± 1.3 mV for 0% (blank), 0.2% and 4% PpIX-encapsulated micelles, respectively (Table 1) . A similar trend was also observed for PpIX-conjugated micelles. We attribute the decrease in ξ potential to the increased surface density of the negatively charged carboxylate (-COO − ) groups in higher PpIXloading micelles.
UV-vis and fluorescence properties of PpIX micelles
The UV-vis absorption spectra of free PpIX monomer, dimer and aggregates are shown in Fig. 2A . In ethyl acetate (EA), PpIX stayed as a monomer with a sharp Soret band at 404 nm. At pH 11 in phosphate buffer, PpIX existed as a dimer and the Soret band blue shifted to 380 nm. At pH 7 in phosphate buffer, a greatly broadened split Soret band (maxima at 352 and 450 nm) of moderate intensity was observed, which correlates with the formation of extended aggregates in solution. In ethyl acetate, PpIX monomer showed bright fluorescence at 632 nm (λ ex = 404 nm, Fig. 2B ). For the PpIX dimer in an aqueous environment (pH 11), the fluorescence intensity decreased with a blue shift of emission peak (λ em = 620 nm, λ ex = 404 nm). For PpIX aggregates at pH 7, the fluorescence intensity became very weak (Fig. 2B) .
The absorption spectra of PpIX-encapsulated micelles were highly dependent on the loading percentage of PpIX (Fig. 2C) . Between 0.04% and 0.2% loading, PpIX existed mostly as a monomer in the micelle core as indicated by the Soret band at 404 nm. At 0.5%, a mixture of PpIX monomers and dimers was present. Above 1% in PpIX loading, PpIX formed aggregates in the micelle core as shown by the broadly split Soret bands. Fluorescence emission of PpIX-encapsulated micelles reached a maximum (λ em = 630 nm) with 0.2% loading density. At higher loading density (N1%), the fluorescence intensity decreased dramatically (Fig. 2D) , consistent with the formation of PpIX aggregates inside the micelle core. For PpIX-conjugated micelles, the absorption spectra showed that PpIX existed mostly as monomers between 0.04 and 0.2% PpIX loading density (Fig. 2E) . At 0.2%, PpIXconjugated micelles had a slightly higher fraction of PpIX in the monomeric state as indicated by the sharper Soret band (half-peak width was 63 nm) than 0.2% PpIX-encapsulated micelles (70 nm). At higher PpIX loading (i.e. 2% or 4%), PpIX existed mostly in the dimeric state as indicated by the blue-shifted Soret band. Similar to PpIXencapsulated micelles, the fluorescence intensity of PpIX-conjugated micelles reached a maximum (λ em = 630 nm) at 0.2% PpIX loading density and decreased significantly at higher PpIX loading (Fig. 2F) . For both PpIX-conjugated and PpIX-encapsulated micelles, we chose 0.2% and 4% loading densities for the subsequent photophysical and PDT efficacy studies. The formation of 1 O 2 was measured by the bleaching of ADPA dye, which was monitored by following the net loss of ADPA absorption at 378 nm over time (Fig. 3) [28, 29] . The relative quantum yields (Φ Δ ) of 1 O 2 generation from different micelle formulations were measured and listed in Table 1 . The Φ Δ values were normalized to 0.2% PpIXconjugated micelles. At 0.2% PpIX loading density, PpIX-encapsulated micelles showed a smaller Φ Δ (0.82) compared to PpIX-conjugated micelles (1.0). At 4% PpIX loading density, PpIX-conjugated micelles showed a much higher relative Φ Δ value (0.48) than PpIX-encapsulated micelles (0.06). The Φ Δ values correlate with the state of the PpIX inside the micelle cores (i.e. Φ Δ, monomer N Φ Δ, dimer NN Φ Δ, aggregates ). Fig. 4 shows the phototoxicity and dark toxicity of different PpIXmicelles in H2009 lung cancer cells after 24 h incubation. For phototoxicity measurement, the cells were irradiated with laser light (λ = 532 nm, power density = 20 mW/cm 2 ) for 10 min. Cell cytotoxicity was measured as the percentage of the viable cells over the untreated cell control (i.e. without micelle incubation and laser exposure). For blank PEG-PLA micelles, the H2009 cells did not show any observable phototoxicity or dark toxicity (data not shown). For PpIX-micelles, several major observations can be made from the PDT data. First, the phototoxicities of 0.2% PpIX-micelles (either encapsulated or conjugated formulation) were significantly lower than those of 4% PpIX-micelles at the same micelle dose. For example, the IC 50 (micelle concentration causing 50% toxicity) values were 51 ± 4 and 21 ± 2 μg/mL (p = 0.002) for 0.2% and 4% PpIX-encapsulated micelles, respectively. The difference was more pronounced in PpIX-conjugated micelles, as illustrated by 58 ± 3 and 3 ± 2 μg/mL (p = 0.0003) for 0.2% and 4% loading density, respectively. These data are contradictory to the 1 O 2 results from the test tube studies where higher Φ Δ values were observed for 0.2% PpIX-micelles. Second, 4% PpIX-encapsulated D) show PpIX existed as monomers at low loading density (b 0.2%) and as aggregates at high loading density (N 1%). In comparison, PpIX-conjugated micelles (E,F) showed that PpIX existed as monomers at low loading density (b0.2%) and as dimers at high loading density (N2%). All the micelles were measured at 2 mg/mL concentration except for those indicated by a dilution factor in C and E for higher loading PpIX-micelles. micelles showed significantly higher dark toxicity than the other micelle formulations. For example, an 80% relative survival was observed at a micelle dose of 8 ± 3 μg/mL; in contrast, none of the other PpIX-micelles showed similar dark toxicity even at the highest micelle dose of 80 μg/mL. Third, 4% PpIX-conjugated micelles demonstrated the largest PDT therapeutic window between the phototoxicity (Fig. 4B , red open circles) and dark toxicity (Fig. 4B , black solid circles). Their phototoxicity was the highest among all micelles while the dark toxicity was comparable to 0.2% PpIX-micelles and much lower than 4% PpIX-encapsulated micelles (Fig. 4) .
PDT efficacy in H2009 lung cancer cells
Intracellular fluorescence of PpIX-micelles
Confocal laser scanning microscopy was used to examine micelle uptake and PpIX release from different PpIX-micelles in H2009 cells over time. Both 0.2% PpIX-micelle formulations had similar fluorescence data; therefore only 0.2% PpIX-encapsulated micelles were shown (Fig. 5A) . At 1 h, the 0.2% PpIX-micelles showed similar intracellular fluorescence over the other two 4% PpIX-micelles. In addition, the fluorescence intensity from the 0.2% PpIX-micelles did not change considerably over the time course from 1 to 24 h (Fig. 5A  and D black bars) . In contrast, the 4% PpIX-encapsulated micelles ( Fig. 5B and D red bars) showed a dramatic increase in fluorescence intensity in H2009 cells from 1 to 4 h (e.g. MFI values were 3.6 ± 1.1 and 20.7 ± 3.7 at 1 h and 4 h, respectively; p b 0.001). The MFI values (20.7 ± 3.7 and 22.4 ± 3.8 at 4 and 24 h, respectively) remained relatively the same from 4 to 24 h (p = 0.52). Unlike the 4% PpIXencapsulated micelles, the intracellular fluorescence intensity of H2009 cells incubated with 4% PpIX-conjugated micelles (Fig. 5C and D blue bars) showed a pattern of steady increase from 2.8 ± 0.4 at 1 h to 15.8 ± 1.6 at 24 h (p b 0.001).
Discussion
The objective of the current study was to develop PpIX-micelles and investigate their photophysical properties and PDT efficacy in cancer cells. PpIX is a potent photosensitizer and although its precursor, 5-ALA (Levulan ® ) has been clinically approved by the FDA, poor membrane permeability was a major limiting factor to achieve the desired clinical efficacy [7] . To overcome this limitation, we aimed to establish a micellar nanocarrier using a biocompatible and biodegradable PEG-PLA copolymer to directly deliver PpIX to cancer cells. Currently, Genexol™, a PEG-PLA micelle formulation for the delivery of paclitaxel, has already been clinically approved for cancer treatment in S. Korea [30] . PpIX is planar molecule with four conjugated pyrrole rings (Fig. 1 ) [31] . PpIX can easily aggregate in aqueous solution and its aggregation behavior has been extensively studied as a function of pH and ionic strength [32, 33] . In the pH range of 0-3, PpIX stays as a monomer with a sharp Soret band at 404 nm and four Q-bands; at pH N 8, PpIX exists as a dimer with a sharp Soret band at 388 nm and four weak Q-bands; and in the pH range 3-7, PpIX forms extended aggregates with two splitting weak Soret bands centered at 350 and 460 nm and four weak Q bands. In these larger aggregates, porphyrins preferentially interact axially through π-π interactions and laterally by edge-to-edge hydrophobic interactions. Formation of intermolecular hydrogen bonds between the carboxylic acids was further hypothesized to contribute to the stabilization of the aggregated structures [32] . At physiological pH (7.4), PpIX has a very low aqueous solubility (~1 μg/ mL) and cannot be directly administered intravenously. Polymeric micelles provide an attractive nanocarrier option for the delivery of PpIX. In this study, we prepared PpIX-micelles by two different strategies: non-covalent encapsulation of PpIX in the hydrophobic cores of micelles and covalent conjugation of PpIX to the core-forming block of the PEG-PLA copolymer (Fig. 1A) . We systematically examined the UV-vis absorption, fluorescence emission, O 2 yields, the two 0.2% PpIXmicelles showed significantly lower phototoxicities compared to the 4% PpIX-micelles at the same micelle dose (Fig. 4) . To investigate this discrepancy, we used confocal laser scanning microscopy to examine the micelle uptake and PpIX release in H2009 cells. For pegylated micelle nanoparticles, cell uptake occurs through fluidic phase endocytosis where nanoparticles are internalized via endosomes and distributed to other intracellular organelles (e.g. lysosome, Golgi) [36, 37] . At 4% drug loading, both micelle formulations had very low fluorescence emissions in cell culture media due to PpIX quenching within the micelle core (Fig. 1) . With 4% PpIX-encapsulated micelles, rapid increases in fluorescence in H2009 cells was observed in the first 4 h (Fig. 5) . We attribute this increase to the release of free PpIX from intact micelles as well as from dissociation of micelles into PEG-PLA unimers and free PpIX, which may further bind to cytosolic proteins or membrane structures leading to further elevated fluorescence. For 4% PpIX-conjugated micelles, higher intracellular fluorescence intensity was also observed over 0.2% PpIX-micelles, suggesting the dissociation of some micelles into PEG-PLA-PpIX unimers. Similar micelle dissociation events were also observed following exposure to fluorogenic PEG-b-poly(ε-caprolactone) micelles under biological conditions [38, 39] . In comparison, 4% conjugated micelles were more stable and had slower micelle dissociation kinetics compared to 4% encapsulated micelles in cell culture medium ( Supplementary  Fig. S1 ), which is consistent with the fast equilibrium for 4% PpIXencapsulated micelles and steady increase for 4% conjugated micelles in intracellular fluorescence measurements.
Our data show that 4% PpIX-conjugated micelles provided the largest PDT therapeutic index compared to the other micelle formulations tested (Fig. 4) . Several factors may contribute to this enhanced performance. First, conjugation of PpIX to the PLA segment prevented the formation of highly aggregated structures as in the 4% PpIX-encapsulated micelles. Consequently, the intact 4% PpIXconjugated micelles had much higher 1 O 2 yield (Φ Δ = 0.48) than 4% PpIX-encapsulated micelles (Φ Δ = 0.06). Second, it is known that high concentrations of free PpIX in cells can induce dark toxicity due to the binding of PpIX to mitochondrial membranes [40] [41] [42] . As such, PpIX conjugation to the PEG-PLA copolymer can effectively prevent the release of free PpIX and avoid dark toxicity. Third, 4% PpIXconjugated micelles showed pattern of steady increase in intracellular fluorescence, which suggest uptake and the slow release of conjugated PpIX inside the cells for improved phototoxicity over time. The prolonged PpIX accumulation may reflect the slower micelle dissociation kinetics to release PEG-PLA-PpIX. In contrast, in 4% PpIX-encapsulated micelles, after an initial increase no changes in fluorescence intensity were observed from 4 to 24 h, which indicates the reaching of equilibrium between PpIX-micelle uptake, PpIX release, and the subsequent clearance of released free PpIX. Although 4% PpIX-encapsulated micelles had higher intracellular fluorescence over 4% PpIX-conjugated micelles in confocal studies, chemical extraction of PpIX from cells showed that PpIX-conjugated micelles had higher intracellular PpIX accumulation than that of encapsulated micelles ( Supplementary Fig. S2 ). These results further verified the protection of PpIX and its photosensitive properties in conjugated micelle formulations, making 4% PpIX-conjugated micelles the best formulation for PDT efficacy. It is interesting to note that for anticancer drug delivery, it is imperative that intact drug molecules be released from nanocarriers. In this study, release of free PpIX from 4% PpIX-encapsulated micelles caused undesirable dark toxicity, while 4% PpIX-conjugated micelles allowed for an effective dose accumulation and higher phototoxicity with reduced dark toxicity in H2009 cells.
Conclusions
This study systematically investigated several PEG-PLA micelle formulations for the delivery of PpIX, a precursor of heme biosynthesis and a potent PDT agent. Non-covalent encapsulation and covalent conjugation strategies were employed to incorporate PpIX into PEG-PLA micelle nanocarriers, which yielded monomeric, dimeric and aggregated forms of PpIX in the micelle core. Although 0.2% PpIXmicelles had higher fluorescence intensity and more efficient 1 O 2 generation in aqueous solution, 4% PpIX-micelles resulted in brighter fluorescence and higher PDT efficacy in cancer cells as a result of PpIX release and micelle dissociation. Among all formulations, 4% PpIXconjugated micelles provided the highest PDT efficacy with relatively low dark toxicity. These results contribute to the mechanistic understanding of the structure-property relationships of PpIXmicelles and establish an optimal micelle formulation (e.g. 4% PpIXconjugated micelles) for subsequent in vivo evaluation in animals.
